BLACKMORES BIO ACE + SELENIUM

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

zinc amino acid chelate, Quantity: 25 mg (Equivalent: zinc, Qty 5 mg); Panax ginseng, Quantity: 25 mg; Allium sativum, Quantity: 10 mg (Equivalent: Allium sativum, Qty 30 mg); calcium pantothenate, Quantity: 55 mg (Equivalent: pantothenic acid, Qty 50.39 mg); d-alpha-tocopheryl acid succinate, Quantity: 82.64 mg; ascorbic acid, Quantity: 550 mg; pyridoxine hydrochloride, Quantity: 25 mg (Equivalent: pyridoxine, Qty 20.57 mg); betacarotene, Quantity: 3 mg; selenium amino acid chelate, Quantity: 7.5 mg (Equivalent: selenium, Qty 75 microgram); thiamine nitrate, Quantity: 9.996 mg; menadione, Quantity: 50 microgram

Available from:

Blackmores Ltd

INN (International Name):

Allium sativum,Ascorbic acid,Betacarotene,Calcium pantothenate,d-alpha-Tocopheryl acid succinate,Menadione,pyridoxine hydrochlor

Pharmaceutical form:

Tablet, film coated

Composition:

Excipient Ingredients: calcium hydrogen phosphate dihydrate; soy polysaccharide; hydrogenated vegetable oil; colloidal anhydrous silica; magnesium stearate; hypromellose; purified talc; Carnauba Wax; macrogol 400; ethylcellulose; methylcellulose; starch sodium octenyl succinate; maize starch; purified water; Maize Oil; dl-alpha-tocopherol

Administration route:

Oral

Therapeutic indications:

A multi vitamin and mineral supplement with herbs. Anti-oxidant. Blackmores BIOACT Anti-oxidant formula has been formulated to help protect the body from potentially harmful free radicals (highly reactive chemicals) which may be generated by lifestyle factors such as excess dietary fats, cigarette smoke, alcohol, indigestion, pollutants and physical or emotional stress. An antioxidant and free radical scavenger.

Product summary:

Visual Identification: Creamy red mottled medium oval shaped clear coated tablet; Container Type: Bottle; Container Temperature: Store below 30 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2005-05-24